TYK2 Inhibitors and Compositions and Methods Thereof
Copyright © Targeted News Service 2024
2024-10-29
ALEXANDRIA, Virginia, Oct. 29 -- LYNK PHARMACEUTICALS CO. LTD., Hangzhou, China has been assigned a patent (No. US 12129250 B2, initially filed Sept. 25, 2023) developed by six inventors Zhaokui Wan, Hangzhou, China; Michael Lawrence Vazquez, Creve Coeur, Missouri; Gurmit Grewal, Lexington, Massachusetts; Xiaodong Li, Hangzhou, China; Lin Su, Hangzhou, China; and Jingyu Wu, Hangzhou, China, for "TYK2 inhibitors and compositions and methods thereof." . . .